Patients with hyposplenia or asplenia have reduced levels of IgM memory B cells and IgM anti-pneumococcal antibodies, causing reduced ability to produce protective antibodies against polysaccharide antigens and hence possible vaccine failure [2,4,5]. This evidence concerns the gene CD40LG and familial isolated congenital asplenia.